Naoto Kuroda1, Suzuko Moritani2, Shu Ichihara2. Show Affiliations » 1. Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi, Japan. 2. Department of Advanced Diagnosis, Division of Pathology, Nagoya Medical Center, Nagoya, Japan.
Abstract
Entities: Disease
Mesh: See more » Adenocarcinoma/metabolismAdenocarcinoma/pathologyBiomarkers, Tumor/metabolismCyclin-Dependent Kinase Inhibitor p16FemaleHumansImmunohistochemistryMiddle AgedNeoplasm Proteins/metabolismTumor Suppressor Protein p53/metabolismUterine Neoplasms/metabolismUterine Neoplasms/pathologyalpha-Fetoproteins/metabolism
Substances: See more » Biomarkers, TumorCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16Neoplasm ProteinsTumor Suppressor Protein p53alpha-Fetoproteins
Year: 2015 PMID: 25393224 DOI: 10.1111/his.12614
Source DB: PubMed Journal: Histopathology ISSN: 0309-0167 Impact factor: 5.087